Open AccessTREATMENT OF CYCLOSPORINE-RELATED ADVERSE EFFECTS BY CONVERSION TO TACROLIMUS AFTER LIVER TRANSPLANTATION
Author(s) -
Johann Pratschke,
R. Neuhaus,
Stefan G. Tullius,
Gary W. Haller,
Sven Jonas,
T Steinmueller,
Wolf O. Bechstein,
P. Neuhaus
Publication year - 1997
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199709270-00029
Subject(s) - tacrolimus , medicine , nephrotoxicity , hyperlipidemia , adverse effect , liver transplantation , transplantation , creatinine , renal function , urology , gastroenterology , side effect (computer science) , kidney , endocrinology , diabetes mellitus , programming language , computer science
Cyclosporine (CsA)-associated side effects include nephrotoxicity, hypertension, neurological disorders, and hyperlipidemia. A considerable share of early and long-term posttransplant morbidity is likely to be drug related.